36 research outputs found

    A novel approach to melt purification of magnesium alloys

    Get PDF
    AbstractA novel low-cost method for melt purification of magnesium alloys, the melt self-purifying technology (MSPT), has been developed successfully based on a low temperature melt treatment (LTMT) without adding any fluxes. The iron solubility in the molten liquid of magnesium and its alloys, and the settlement velocity of iron particles were calculated. It is shown that the low temperature melt treatment is an effective method to decrease the impurity Fe content in magnesium and its alloys. Without any additions, the Fe content in the AZ31 alloy was reduced to 15ā€‰ppm from the initial 65ā€‰ppm, and the Fe content in the AZ61 melt was decreased to 20ā€‰ppm from the initial 150ā€‰ppm after the low temperature melt treatment. The results also showed that the Fe content in AM60 and AM50 dropped to 15 and 18ā€‰ppm, respectively, from the initial 150ā€‰ppm after the low temperature melt treatment. For ZK 60, the Fe content in the melt down to less than 5ā€‰ppm was achieved. After the low temperature melt treatment, the Si content in the above alloys was also decreased obviously

    Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients

    Get PDF
    CD4+ T cells serve as master regulators of the adaptive immune response to HBV. However, CD4+ T-cell subsets are heterogeneous, and it remains unknown how the antiviral agents affect the different CD4+ T cell subtypes. To this end, the expressions of signature transcription factors and cytokines of CD4+ T-cell subtypes were examined in hepatitis B patients before and after treatment with telbivudine. Results showed that, upon the rapid HBV copy decrease induced by telbivudine treatment, the frequencies and related cytokines of Th17 and Treg cells were dramatically decreased, while those for Th2 cells were dramatically increased. No obvious changes were observed in Th1 cell frequencies; although, IFN-Ī³ expression was upregulated in response to telbivudine treatment, suggesting another cell source of IFN-Ī³ in CHB patients. Statistical analyses indicated that Th17 and Tr1 (a Treg subtype) cells were the most sensitive subpopulations of the peripheral blood CD4+ T cells to telbivudine treatment over 52ā€‰weeks. Thus, Th17 and Tr1 cells may represent a suitable and effective predictor of responsiveness during telbivudine therapy. These findings not only improve our understanding of hepatitis pathogenesis but also can aid in future development of appropriate therapeutic strategies to control viral hepatitis

    Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B

    Get PDF
    Background/Aims We investigated the dynamics of serum HBV pre-genomic RNA (pgRNA) and hepatitis B core-related antigen (HBcrAg) in patients receiving nucleos(t)ide analogues (NAs) and their predictability for favourable suppression of serum hepatitis B surface antigen (HBsAg). Methods Serum viral biomarkers were measured at baseline, weeks 4, 12, 24, 36, and 48 of treatment. Patients were followed up thereafter and serum HBsAg level was measured at end of follow-up (EOFU). Favourable HBsAg response (FHR) was defined as ā‰¤100 IU/mL or HBsAg seroclearance upon EOFU. Results Twenty-eight hepatitis B e antigen (HBeAg)-positive and 36 HBeAg-negative patients (median, 38.2 years old; 71.9% male) were recruited with median follow-up duration of 17.1 years (interquartile range, 12.8ā€“18.2). For the entire cohort, 22/64 (34.4%) achieved FHR. For HBeAg-positive patients, serum HBV pgRNA decline at week 4 was significantly greater for patients with FHR compared to non-FHR (5.49 vs. 4.32 log copies/mL, respectively; P=0.016). The area under the receiver-operating-characteristic curve (AUROC) for week 4 HBV pgRNA reduction to predict FHR in HBeAg-positive patients was 0.825 (95% confidence interval [CI], 0.661ā€“0.989). For HBeAg-negative patients, instead of increase in serum HBcrAg in non-FHR patients, FHR patients had median reduction in HBcrAg at week 4 (increment of 1.75 vs. reduction of 2.98 log U/mL; P=0.023). The AUROC for week 4 change of HBcrAg to predict FHR in HBeAg-negative patients was 0.789 (95% CI, 0.596ā€“0.982). Conclusions Early on-treatment changes of serum HBV pgRNA and HBcrAg at 4 weeks predict HBsAg seroclearance or ā‰¤100 IU/mL in NA-treated CHB patients upon long-term FU

    Effects of Sn addition on microstructure and mechanical properties of Mg-Zn-Al alloys

    No full text
    The effects of Sn addition (0, 0.5, 1.0, 2.0 and 3Ā wt%) on microstructure of Mg-4Zn-1.5Al alloy in cast and extruded states were investigated, and the mechanical properties of as-extruded Mg-4Zn-1.5Al-xSn studied. The experimental results showed that the as-cast Mg-4Zn-1.5Al alloy was composed of two phases Ī±-Mg and Mg32 (Al, Zn) 49, while Sn-containing alloys consisted of Ī±-Mg, Mg32 (Al, Zn)49 and Mg2Sn phases, and Mg32 (Al, Zn)49 was not detected after extruding due to that the most of them dissolved into the matrix during the homogenized treatment. The addition of Sn refined the grains of as-cast and as-extruded Mg-Zn-Al alloys obviously. It was noted that the basal texture intensity reduced with increasing Sn content significantly in as-extruded Mg-Zn-Al alloys. The tensile tests results indicated that Sn addition improve the tensile strength of the extruded alloys, while it had a harmful effect on the ductility. When the addition of Sn was 2Ā wt%, the ultimate tensile strength (UTS), yield strength (YS) and elongation (Īµf) of the alloy were 280Ā MPa, 147Ā MPa and 17.4%, respectively

    Thermosensitive hydrogel coupled with sodium ascorbyl phosphate promotes human umbilical cord-derived mesenchymal stem cell-mediated skin wound healing in mice

    No full text
    Abstract Poor survival and restricted function of transplanted stem cells are regarded as limiting their efficacy in wound recovery greatly. Consequently, it is necessary to identify innovative therapeutic strategies to solve these issues. Firstly, the biological effect of PF-127 hydrogel alone and in combination with SAP on the survival, and migration of cultured HUCMSCs was assessed by cell viability, apoptosis, and scratch wound assays. S. aureus and E. coli were used to evaluate the antibacterial activity of PF-127 plus SAP combination. Further, the ability of HUCMSCs-conditioned medium (HUCMSCs-CM) to promote the angiogenesis and migration of human umbilical vein endothelial cells (HUVECs) in vitro was evaluated using tube formation and transwell migration assays. Finally, the HUCMSCs embedded in PF-127 plus SAP scaffold were administered onto miceā€™s excisional cutaneous wound bed. Histological and immunohistochemical analyses were employed to investigate the wound healing capacity as well as cellular responses of PF-127/HUCMSCs/SAP hydrogel. PF-127 showed cytotoxicity on HUCMSCs, whereas the addition of SAP significantly promoted cell viability and alleviated apoptosis of HUCMSCs encapsulated in PF-127 hydrogel in vitro. SAP supplementation substantially abrogated the inhibiting effect of PF-127 on the migration of HUCMSCs in vitro. The combination of PF-127 and SAP exerted an obvious bacteriostatic function on S. aureus and E. coli. Moreover, the co-treatment with SAP could remarkably enhance the stimulative effect of HUCMSCs-CM on the angiogenesis and migration of HUVECs in vitro. PF-127 combined SAP-embedded HUCMSCs transplantation resulted in a potently accelerated wound healing process, promoted the number of proliferating cells and newly formed blood vessels, as well as enhanced expression of vascular endothelial growth factor. PF-127 coupled with SAP contributes to HUCMSCs-mediated traumatic wound closure in mice by promoting cell survival, antibacterial action, and angiogenesis. Our results offered a theoretical foundation for the clinical treatment of traumatic skin defects

    Facile spray drying synthesis of porous structured ZnFe2O4 as high-performance anode material for lithium-ion batteries

    No full text
    Porous ZnFe2O4 nanorods have been successfully prepared by a simple spray-drying process followed by sintering. The structure and morphology of the samples were characterized by X-ray diffraction, field emission scanning electron microscopy and transmission electron microscopy. The porous structured ZnFe2O4 materials are successfully used as potential anode material for lithium-ion batteries. Electrochemical results show that the anodes exhibit good cycling performance and rate capability. The anode exhibits initial discharge capacity of approximately 1459 mAh gāˆ’1 with an initial coulombic efficiency of 77.8% at a constant density of 100 mA gāˆ’1. The discharge capacity of the ZnFe2O4 retained 1458 mA h gāˆ’1 after 120 cycles at the current rate of 100 mA gāˆ’1 and 456 mA h gāˆ’1 could be obtained at the current density of 5000 mA gāˆ’1 after 200 cycles. The discharge capacities can still be as high as 778 mAh gāˆ’1 at a high rate of 3000 mA gāˆ’1. Such remarkable electrochemical properties could be ascribed to the unique porous morphology with large surface area and porosity that were beneficial to facilitate the diffusion of Li ions and electrolyte into the electrodes, meanwhile prevent volume expansion/contraction during lithiation/dislithiation processes

    Synthesis of intertwined Zn0.5Mn0.5Fe2O4@CNT composites as a superior anode material for Li-ion batteries

    No full text
    Nanocrystalline ZnFe2O4, Zn0.5Mn0.5Fe2O4, and Zn0.5Mn0.5Fe2O4@CNT composites have been successfully prepared by a facile and high-yield co-precipitation method. All the samples as the anode materials were characterized by X-ray diffraction, thermogravimetry, and electrochemical measurements. It has been found that the appropriate Mn doping and CNTs intertwining actively affect the formation of uniform morphology and improve the cycling stability and rate capability. The Zn0.5Mn0.5Fe2O4@CNT composites exhibit excellent electrochemical performance as the anode material, with enhanced reversible capacity (1374.8 mAh gāˆ’1 after 100 cycles at the current density of 100 mA gāˆ’1) and good rate capability (933.5 mAh gāˆ’1 at 500 mA gāˆ’1, 809.9 mAh gāˆ’1 at 1000 mA gāˆ’1, 634.2 mAh gāˆ’1 at 1500 mA gāˆ’1). We also present the crystal structure and Li-ion insertion mechanism for the above materials

    3-Dimensional cuboid structured ZnFe2O4@C nano-whiskers as anode materials for lithium-ion batteries based on the in situ graft polymerization method

    No full text
    3-Dimensional cuboid structured ZnFe2O4@C nano-whiskers anode materials have been successfully synthesized via an in situ graft copolymerization method and the subsequent calcination process. Polystyrene-acrylonitrile (PSA) serves as the coating layer, which plays an important role in the calcination process. The final electrode materials were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The results of electrochemical tests demonstrate an excellent electrochemical performance, including good rate capability (over 700 mA h gāˆ’1 at the current density of 3.2 A gāˆ’1) and good cycling performance (a reversible capacity of 1722 mA h gāˆ’1 after 120 cycles with coulombic efficiency of 98.4%). Therefore, we believe that the proposed work may be a potential method to assist ZnFe2O4 to be a quite promising alternative anode material for lithium-ion batteries (LIBs)

    Biomolecular Condensates Decipher Molecular Codes of Cell Fate: From Biophysical Fundamentals to Therapeutic Practices

    No full text
    Cell fate is precisely modulated by complex but well-tuned molecular signaling networks, whose spatial and temporal dysregulation commonly leads to hazardous diseases. Biomolecular condensates (BCs), as a newly emerging type of biophysical assemblies, decipher the molecular codes bridging molecular behaviors, signaling axes, and clinical prognosis. Particularly, physical traits of BCs play an important role; however, a panoramic view from this perspective toward clinical practices remains lacking. In this review, we describe the most typical five physical traits of BCs, and comprehensively summarize their roles in molecular signaling axes and corresponding major determinants. Moreover, establishing the recent observed contribution of condensate physics on clinical therapeutics, we illustrate next-generation medical strategies by targeting condensate physics. Finally, the challenges and opportunities for future medical development along with the rapid scientific and technological advances are highlighted
    corecore